Ascendis (ASND) 2025 Earnings: Q4 Insights and Outlook
As the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...
Discover effective ways to increase your investment portfolio performance. Enhance your returns and achieve your financial goals.
23,604 articlesAs the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...
Investors are watching FIGS as the stock shows signs of momentum. This article breaks down the reasons behind figs st...
As Netflix prepares for its July 16 report, a developing narrative about live channels could be a pivotal signal for ...
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Tariffs grabbed headlines, but markets can react to other forces just as sharply. This guide breaks down two addition...
Dreaming of a portfolio that compounds for decades? This article lays out three growth stocks hold forever that pass ...
The 2026 Hedge Fund Alternative Manager Forum brought together leaders to share how AI, data, and differentiated stra...
A midweek market jolt hit the memory space as a rival unveiled AI driven compression and Sandisk announced a major in...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Investors are weighing whether now is the time to buy SpaceX's stock after a pullback. This guide breaks down the dec...
NASA issued a comprehensive review of Boeing's Starliner program, yet the agency has not pulled the plug. Here’s how ...